Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
157-165
Author(s):
L. Mastalerz, M. Sanak and A. Szczeklik
The Basophil Granulocyte in Allergic Reactions: Experimental Models and their Use for the Identification of Drugs with Effects or Side Effects on Basophils
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
167-180
Author(s):
Lars K. Poulsen, Sha Quan, Claudia Krag, Michael H. Platzer and Per Stahl Skov
New Developments on Thromboxane and Prostacyclin Modulators Part I: Thromboxane Modulators
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
1223-1241
Author(s):
Jean-Michel Dogne, Xavier de Leval, Julien Hanson, Michel Frederich, Bernard Lambermont, Alexandre Ghuysen, Angela Casini, Bernard Masereel, Ke-He Ruan, Bernard Pirotte and Philippe Kolh
Protein Phosphatase Inhibition: Structure Based Design. Towards New Therapeutic Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1139-1159
Author(s):
Jennette A. Sakoff and Adam McCluskey
5-Lipoxygenase: Regulation and Pharmacology
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
201-223
Author(s):
Oliver Werz
Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
899-913
Author(s):
Z. Wu, I. A. M. MacPhee and D. B. G. Oliveira
Small Molecule Antagonists of the Tachykinin NK2 Receptor [General Reviews]
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
331-340
Author(s):
Daniela Fattori, Maria Altamura and Carlo Alberto Maggi
Cysteinyl Leukotriene Receptor Antagonists and Thromboxane Synthase Inhibitors: New Targets to Treat Asthma
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
9-18
Author(s):
Lidia M. Lima, Carlos Alberto M. Fraga and Eliezer J. Barreiro
Novel Drugs for Inflammatory Lung Diseases
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
39-52
Author(s):
Juliane Platz and Robert Bals
Drugs that Target Lipoxygenases and Leukotrienes as Emerging Therapies for Asthma and Cancer
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
19-33
Author(s):
Candace D. Poff and Michael Balazy